Canaccord Genuity has initiated coverage on the following companies:
Hi-Tech Pharmacal HITK Buy, $45 PT
MAP Pharmaceuticals MAPP Buy, $24 PT
Pernix Therapeutics PTX Buy, $15 PT
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
